How M.D. was paid
$25.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Christopher A. Kroeger, M.D.President and Chief Executive Officer | $655,250 | $12,296,267 | $12,322,406 | $331,000 | $19,331 | $25,624,254 |
| Vishwas SetiaChief Financial Officer | $432,294 | $3,200,500 | $2,367,617 | $183,000 | $19,153 | $6,202,564 |
| Erin Pennock Foff, M.D., Ph.D.Chief Medical Officer | $531,000 | $2,871,478 | $2,636,670 | $194,000 | $20,851 | $6,254,000 |
What changed and why
- $25.6MCEO Christopher A. Kroeger received total compensation of $25,624,254 in 2025 compared to $8,789,142 in 2024.
- The increase was primarily driven by significant stock and option awards granted in connection with financing and initial public offering activities.
- Base salaries for named executive officers increased for fiscal year 2025 and further adjustments were approved for 2026.
- Annual performance-based bonuses were awarded based on clinical, non-clinical, financing, and budgetary goals.
- Equity incentive awards included both restricted stock units and stock options vesting over multi-year periods.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.